The prevalence of HIV in Mexico among persons aged 15-49 has remained relatively stable over the years. From 2013 to 2015, the prevalence stood at 0.3%. A slight increase occurred in 2016, raising the prevalence to 0.4%, where it has remained constant up to 2023. The year-on-year variation in prevalence was significant only in 2016, with a 33.33% increase compared to the previous year. The Compound Annual Growth Rate (CAGR) for 2016 to 2020 was 5.92% due to this increase. However, from 2021 onwards, both the year-on-year variation and the CAGR have been 0%, indicating no change.
In 2023, the prevalence of HIV in Mexico stood at 0.4%, and this value is expected to remain unchanged through the forecast period up to 2028. Consequently, the forecasted five-year CAGR and growth rate are both estimated to be 0%.
Future trends to watch for include potential impacts of healthcare policies, advancements in HIV treatment and prevention, as well as public awareness initiatives. Monitoring these factors will be crucial to understanding any deviations from the current stable trend in the prevalence of HIV in Mexico.
